Ontology highlight
ABSTRACT:
SUBMITTER: Hooft van Huijsduijnen R
PROVIDER: S-EPMC6991954 | biostudies-literature | 2020 Jan
REPOSITORIES: biostudies-literature
Hooft van Huijsduijnen Rob R Kojima Somei S Carter Dee D Okabe Hisafumi H Sato Akihide A Akahata Wataru W Wells Timothy N C TNC Katsuno Kei K
PLoS neglected tropical diseases 20200130 1
In the past two decades there has been a significant expansion in the number of new therapeutic monoclonal antibodies (mAbs) that are approved by regulators. The discovery of these new medicines has been driven primarily by new approaches in inflammatory diseases and oncology, especially in immuno-oncology. Other recent successes have included new antibodies for use in viral diseases, including HIV. The perception of very high costs associated with mAbs has led to the assumption that they play n ...[more]